Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan Watkins

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Molecular Cancer Therapeutics|March 4, 2010
Molecular pharmacology and antitumor activity of PHT-427, a novel Akt/phosphatidylinositide-dependent protein kinase 1 pleckstrin homology domain inhibitorEmmanuelle J Meuillet, Song Zuohe, Robert Lemos, et al.
Journal of Hepatology|March 8, 2024
Syngeneic murine models with distinct immune microenvironments represent subsets of human intrahepatic cholangiocarcinomaJennifer L Tomlinson, Binbin Li, Jingchun Yang, et al.
PNAS Nexus|March 26, 2024
A small molecule MST1/2 inhibitor accelerates murine liver regeneration with improved survival in models of steatohepatitisRyan Watkins, Ana Gamo, Seung Hyuk Choi, et al.
Hepatology (Baltimore, Md.)|September 29, 2025
Multiomics combined with machine learning defines unique molecular subtypes of cholangiocarcinoma and identifies TNK1 as a therapeutic targetDong-Gi Mun, Erik Jessen, Jennifer L Tomlinson, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Molecular Cancer Therapeutics|March 4, 2010
Molecular pharmacology and antitumor activity of PHT-427, a novel Akt/phosphatidylinositide-dependent protein kinase 1 pleckstrin homology domain inhibitorEmmanuelle J Meuillet, Song Zuohe, Robert Lemos, et al.
Journal of Hepatology|March 8, 2024
Syngeneic murine models with distinct immune microenvironments represent subsets of human intrahepatic cholangiocarcinomaJennifer L Tomlinson, Binbin Li, Jingchun Yang, et al.
PNAS Nexus|March 26, 2024
A small molecule MST1/2 inhibitor accelerates murine liver regeneration with improved survival in models of steatohepatitisRyan Watkins, Ana Gamo, Seung Hyuk Choi, et al.
Hepatology (Baltimore, Md.)|September 29, 2025
Multiomics combined with machine learning defines unique molecular subtypes of cholangiocarcinoma and identifies TNK1 as a therapeutic targetDong-Gi Mun, Erik Jessen, Jennifer L Tomlinson, et al.
Pageof 2